ORIGINAL RESEARCH ARTICLE

I
n patients undergoing coronary artery bypass grafting (CABG), the use of the left internal thoracic artery to bypass the left anterior descending (LAD) coronary artery has been standard for the past 30 years, 1, 2 and is associated with improved survival and decreased repeat revascularization. [3] [4] [5] Many studies have reported an association of a long-term survival benefit for patients undergoing CABG with the use of 2 arterial grafts compared with 1 arterial graft. [6] [7] [8] [9] [10] There is less evidence regarding the incremental effect of increased arterial revascularization, specifically a third arterial graft compared with 2 arterial grafts. Previous reports have been limited to either single center experiences or multi-center studies comprising small sample sizes that preclude robust long-term outcome analyses. [11] [12] [13] [14] [15] A published meta-analysis of studies using propensity-matching attempted to overcome these limitations, with analyses of pooled data demonstrating better survival for CABG with 3 versus 2 arterial grafts on long-term mortality. 16 Given a lack of consensus on the incremental effect of a third arterial graft in the longterm, we sought to investigate outcomes associated with 3 versus 2 arterial grafts in a population-level, multi-institutional study, evaluating both long-term survival and major adverse cardiac and cerebrovascular events (MACCE). In addition, as a secondary objective, we compared CABG with 2 or 3 arterial grafts (multiple arterial grafts; MAG) with CABG using a single arterial graft (SAG).
METHODS
The privacy policy from the Institute of Clinical Evaluative Sciences (ICES), which holds all databases used for this study, precludes sharing any study data to other researchers.
Study Design
All primary isolated CABGs performed in the province of Ontario, Canada, from 11 institutions, from October 2008 to March 2016, were identified through linkages of 5 administrative governmental databases. The CorHealth Registry (formerly Cardiac Care Network Registry) prospectively collects information on all adult cardiac surgical and interventional cardiology procedures, in Ontario. The number of diseased vessels was calculated based on the following information provided by the CorHealth Registry: any coronary artery vessel stenosis >70% stenosis (yes or no), with the exception of the left main, which was >50% stenosis (yes or no). Patients were then linked through a unique patient identifier to 4 additional administrative databases. The Canadian Institute for Health Information Discharge Abstract Database was used to determine in-hospital and follow-up outcomes. The Registered Persons Database, was used to identify all-cause death. The Ontario Health Insurance Plan (OHIP), a database of physicians' billings, was used to identify the number of arterial and overall grafts. Linkage to the Canadian National Census database was used to determine patients' socioeconomic status and access to health care, through income quintile and distance from residence to health care provider, respectively. We excluded patients who did not have a valid health card number as these patients were either international or out of the province individuals and could not be followed up after surgery. Nevertheless, if Ontario residents with valid health card numbers presented with an event in another province, the event was still captured.
All described databases are held securely at ICES, which is a "prescribed entity" under Ontario's health information privacy legislation. The Institutional Review Boards of ICES and CorHealth approved this study to be conducted under a waiver of individual patient informed consent.
Outcomes
The primary outcome for this study was time to first event of a composite of death, myocardial infarction (MI), stroke, or repeat revascularization (MACCE). Secondary outcomes included the individual events of the primary outcome. Tertiary outcomes included the following in-hospital events: death, stroke, MI, new onset of atrial fibrillation, kidney dysfunction requiring dialysis, red cell transfusion, and the length of stay.
The strategy to identify total number of grafts and number of arterial grafts was based on the OHIP coding claims. The following OHIP codes were utilized: double coronary bypass (R743); each additional coronary bypass (E654); and a supplemental code used for arterial grafts for coronary bypass (E652). The total number of grafts equals R743+(E654×N). The total number of arterial grafts equals E652×N. For example, a quadruple bypass using bilateral internal thoracic arteries, a radial, and a SVG is coded as R743+E654×2 (quadruple bypass), and E652×3 (3 arterial grafts). The algorithm was evaluated under an internal chart review validation process, comparing the codes against the operative note. Fifty random CABG cases were reviewed and compared with our coding strategy, resulting in a positive predictive value of 0.94. After confirming our strategy's accuracy, all CABG cases with 3 or more bypasses were identified and stratified according to the number of arterial grafts utilized. To identify long-term
Clinical Perspective
What Is New?
• The use of >1 arterial graft is increasing in the contemporary era, in Ontario, Canada.
• Multiple arterial graft coronary artery bypass graft (CABG) is associated with superior outcomes compared with single arterial graft.
• CABG with 3 arterial grafts is not associated with increased in-hospital death but is also not associated with better clinical outcomes up to 8 years, compared with CABG with 2 arterial grafts.
What Are the Clinical Implications?
• Multiple arterial graft CABG should be the procedure of choice for patients undergoing CABG using either 2 or 3 arterial grafts, in appropriate patients with reasonable life expectancy. 
Statistical Analysis
Continuous variables are reported as mean±standard deviation (SD) or median (interquartile range). Categorical variables are reported as frequencies and percentages. To check for normality, continuous variables were assessed using the KolmogorovSmirnov test. A 2-tailed P value <0.05 was considered statistically significant. All statistical analyses were conducted using SAS Enterprise Guide, version 6.1 (SAS Institute, Cary, NC). As per ICES policy, all cells with fewer than 5 events were presented as "< 5" to avoid potential patient identification.
Propensity score matching (PSM) was utilized to adjust for prespecified clinically relevant baseline characteristics that were potentially confounding variables. We first calculated propensity scores using logistic-regression models with all baseline variables listed in Table 1 , including patients' socioeconomic status, surgical risk factors, and extent of coronary artery disease. For patients undergoing CABG with ≥3 bypass grafts, patients having surgery with 3 arterial grafts (3Art) were matched 1:1 with patients undergoing CABG with 2 arterial grafts (2Art), using the propensity score with a caliper of 0.2 of the standard deviation of the logit of the propensity score without replacement. 18, 19 Standardized mean differences were determined to compare baseline characteristics of all patients; a standardized mean difference < 0.1 was considered as an indicator of good balance between groups. 20 A sensitivity analysis was performed using a 2-level hierarchical logistic regression model that accounted for patientspecific demographic and clinical characteristics, as well as the clustering of patients within the same hospital using a hospital-specific random effects. In addition, the overall number of bypasses grafted was added to the propensity score model, in an effort to further adjust for a residual imbalance of the extent of coronary artery disease.
Additional PSM analysis was performed to evaluate the use of >1 arterial graft compared with a single arterial graft as a positive control in patients who underwent CABG with ≥3 bypass grafts, using similar methodology. Patients with 2 or 3 arterial grafts (multiple arterial grafting -MAG group) were compared with patients with a single arterial graft (SAG group).
Time-to-event analyses were performed using Cox proportional hazards models to compare MACCE and survival. Acute MI, stroke, and repeat revascularization were compared using the Fine-Gray model adjusting for death as a competing risk. 21 Hazard ratios (HR) were determined at 30 days and 1, 5, and 8 years after surgery, with assessment of proportional hazard assumption at each time point, based on the P value of the interaction term of time and group, with robust standard errors to account for clustering in matched pairs. Cumulative incidence curves were generated for MACCE and survival. Cumulative incidence functions were generated for MI, stroke, and repeat revascularization, with robust standard errors to account for the clustering in matched pairs, by specifying the propensity score matched pair identification in the Fine-Gray models.
Prior to matching, baseline demographics were compared using unpaired t test (continuous data) or χ 2 (categorical data). Tertiary in-hospital outcomes were compared between the propensity matched cohorts utilizing McNemar test for categorical outcomes, and parametric (paired t-tests) or nonparametric (Wilcoxon signed-rank) tests for continuous outcomes.
RESULTS
Study Population
From October 2008 to March 2016, 50 230 cases of primary isolated CABG were identified, with 3044 (6.1%) cases with 3 arterial grafts and 8235 (16.4%) using 2 arterial grafts, totaling 11 279/50 230 (22.5%) CABG with >1 arterial conduit ( Figure I in the online-only Data Supplement). The unadjusted and post PSM baseline demographics are outlined in Table 1 . The 2 groups were generally low risk and similar for many of the baseline variables before matching. Within the 2 arterial group versus 3 arterial group, there were statistically more patients with hypertension (72.7% versus 67.6%, P<0.01), diabetes mellitus (38.3% versus 32.6%, P<0.01), hyperlipidemia (75.6% versus 70.9%, P<0.01), previous MI (22.1% versus 19.5%, P<0.01), and a higher proportion of patients with Canadian Cardiovascular Society angina class ≥ 3 (26.1% versus 24.9%, P<0.01). The 3Art patients had a higher proportion of patients with New York Heart Association class ≥ 3 (7.6% versus 4.2%, P<0.01), and a primary residence location in rural area (20.8% versus 11.5%, P<0.01). After PSM, 2,789 patient pairs were formed. The baseline standardized mean differences were all <0.1 after matching.
In-Hospital Outcomes
The operative and postoperative outcomes of the PSM cohorts are presented in Table II in the online-only Data Supplement. In the PSM cohorts, the total number of bypass grafts was statistically greater in the 3Art compared with the 2Art group (3.80±0.88 versus 3.73±0.82, P<0.01, respectively). There were more radial grafts in the 3Art group (79.3% versus 65.6%, P<0.01). In-hospital death (0.8% versus 0.5%, P=0.26), MI (1.1% versus 0.6%, P=0.11), stroke (0.6% versus 0.5%, P=1.00), new onset of atrial fibrillation (13.7% versus 13.4%, P=0.76), kidney dysfunction requiring dialysis (0.8% versus 0.6%, P=0.53), blood transfusion (45.4% 43.1%, P=0.08), and length of stay (6 [5-7] versus 6 [5] [6] [7] days, P=0.56) did not differ between 3 versus 2Art groups, respectively.
Primary Outcome: MACCE
The primary study outcome is presented in Table 2 . The mean and maximum follow-up was 4.2 and 8.5 years. Figure 1 outlines the cumulative incidence of MACCE for both PSM cohorts. Cumulative incidence of MACCE 
Secondary Outcomes
Death Long-term death, MI, stroke, and repeat revascularization are presented in Table 2 . Cumulative incidence of death over 8 years is presented in Figure 2 for the PSM groups. At 8 years, death was 15%, 95% CI 13% to 
Myocardial Infarction
The use of 3 arterial grafts was not associated with lower MI incidence post-CABG at 30-day or 1-, 5-, or at 8-year follow-up ( Table 2 ). The cumulative incidence of MI adjusted for death as a competing risk at 8-year follow-up, for 3 versus 2 arterial grafts, was 6%, 95% CI 5% to 8%, and 5%, 95% CI 4% to 7%, respectively (HR, 1.15; 95% CI, 0.87-1.51; P=0.33; Figure 3 ).
Stroke
The cumulative incidence of stroke adjusted for death as a competing risk was not significantly different throughout follow-up for the 2 cohorts, except at 5 years (Table 2) . At 8 years, the stroke incidence was 4%, 95% CI 3% to 5% in the 3Art group compared with 3%, 95% CI 2% to 4% in the 2Art group (HR, 1.40; 95% CI, 0.95-2.06; P=0.09) ( Figure II in the online-only Data Supplement).
Repeat Revascularization
Using 3 arterial grafts was not associated with less repeat revascularization post-CABG during follow-up (Table 2). The cumulative incidence of repeat revascularization at 8 years, for 3 versus 2 arterial grafts, was 8%, 95% CI 7% to 10% versus 8%, 95% CI 6% to 9% respectively, (HR, 1.04; 95% CI, 0.82-1.32; P=0.72; Figure III in the online-only Data Supplement).
Sensitivity Analysis
A sensitivity analysis of 3 versus 2Art accounting for the institution where the CABG was performed and including the total number of bypasses in the PSM resulted in 2481 pairs. Baseline characteristics are described in Table III in the online-only Data Supplement. The mean total number of bypass grafts was not different between groups (3.87±0.86 for each). Use of a radial artery was higher in the 3Art group (84.5 versus 74.6%, P<0.01). There was no difference in in-hospital outcomes (Table IV in the online-only Data Supplement) 
Single Versus Multiple Arterial Grafting
Unadjusted and post PSM baseline demographics are outlined in Table VI in the online-only Data Supplement. The groups were substantially different. SAG patients were older (67.1±9.6 years versus 63.2±9.9 years, P<0.01) and with a higher incidence of most comorbidities, prior to matching. After PSM, 8629 patient pairs were formed. The baseline standardized mean differences were all <0.10 post matching. Postoperative in-hospital outcomes of the PSM cohorts are presented in Table VII in the online-only Data Supplement. The total number of bypass grafts was higher in the MAG compared with the SAG group (3.76±0.82 versus 3.52±0.70, P<0.01, respectively). The use of a radial artery was higher in the MAG cohort (69.9% versus 3.2%, P<0.01). MAG was associated with a lower incidence of postoperative in-hospital stroke (0.6% versus 0.9%, P=0.01) and blood transfusion (45.3% versus 56.2%, P<0.01) compared with SAG. There was no significant difference in other inhospital outcomes analyzed. Table 3 
DISCUSSION
The most important finding of this study is that CABG with 3 arteries was not associated with better MACCE, survival, or other clinical outcomes at 8-year follow-up compared with CABG with 2 arterial grafts. Moreover, use of additional arterial conduit was not associated with a higher risk of in-hospital adverse events. Third, the use of MAG was associated with better outcomes in the short and long-term, compared with single arterial CABG. Fourth, MAG CABG has increased in this contemporary multi-institutional series (22.5%), compared with previous reports, although patients selected for arterial grafting (either 2 or 3 arterial grafts) were of lower risk than patients with only a single arterial graft.
Conflicting reports regarding the association of a third arterial graft with better outcomes, compared with 2 arterial grafts, have precluded any definitive conclusions. 22, 23 In the absence of a randomized, controlled trial, the best evidence comes from retrospective studies adjusted for potential confounders. 16 Two individual reports have demonstrated an association of better long-term results with 3 arterial grafts after PSM.
11,12 Glineur 11 described the largest magnitude of association with better outcomes with this strategy, but with a small group of 3 arterial graft patients (93 patients). This study compared bilateral internal thoracic arteries (BITA) + gastroepiploic arterial graft versus BITA + saphenous venous graft in a single center. The third arterial conduit group had higher compared BITA + radial artery versus BITA + saphenous vein. At 15 years, BITA + radial patients experienced better risk-adjusted survival (82±5.2% versus 72±6.0%, P=0.021). In our study, despite a larger sample size, we did not observe any association of better late outcomes with 3Art CABG. A possible explanation for our study findings is that the 3 and 2 arterial graft patients were generally low risk, and the outcomes in both cohorts of patients were excellent. In addition, the mean and latest follow-up was 4.2 and 8.5 years, respectively, and perhaps longer follow-up is required to observe a difference in outcomes in our study, coincident with the expected accelerated late vein graft failure. We were also concerned about a potential residual imbalance regarding the extent of coronary disease following PSM (based on the higher number of bypasses in the 3Art group) and the influence of institution where the procedure was performed. A sensitivity analysis, accounting for institution and matching the total number of bypasses performed did not show any difference between strategies.
Our study group involved younger patients than the average CABG population seen in other studies. Wu et al 24 described the demographics of 8597 patients undergoing isolated CABG in New York State, with a mean age of 66 years. In our data, after propensity-matching, patients undergoing isolated surgical revascularization with three and two arterial graft patients had a mean age of 62 years. With a follow-up <10 years, no differences emerged; longer follow-up may be required, as observed by other reports. 11, 12 Surprisingly, the rate of MAG with 3 or 2 arteries was 22.5% of all isolated CABGs performed in Ontario. In a previous report using the same registry, analyzing patients who underwent isolated CABG from 1991 to 2001, only 6515 of 53 727 cases (12%) had 3 or 2 arterial grafts. 25 Furthermore, a study reported from the Society of Thoracic Surgeons National Database in the United States, in 2009, showed that <10% of CABGs are 
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multi-arterial. 26 The higher incidence in our study might reflect the adoption the American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) and European Association for Cardio-Thoracic Surgery (EACTS)/European Society of Cardiology (ESC) guidelines recommendation for multiarterial revascularization in case of patients with reasonable life expectancy (IIb and IIa, respectively), published over the past decade. 27 The primary objective of this study was to assess the potential association of incremental arterial revascularization, specifically 3 versus 2 arteries, with better outcomes, in a population level observational study. In the secondary analysis, we compared MAG versus SAG, as a positive control. The baseline differences between these 2 groups were vast, indicating the surgeon's selection of a MAG strategy for a healthier population. After PSM, the mid-and long-term results were different, with a clear association of MAG with better outcomes, up to 8 29 did not observe any difference in a randomized controlled trial of left internal thoracic artery versus BITA. An important limitation of the trial was the high incidence (23%) of radial artery grafts in the left internal thoracic artery arm.
Our study does not identify the exact arterial graft configuration utilized. We assumed that the arterial grafts used in any individual patient were a single radial artery and a single or bilateral ITA grafts-bilateral radial harvesting and gastroepiploic arteries are not used frequently in Ontario, as per the senior author's knowledge. We then may infer the most common grafting strategies. What was clear, however, is that the radial artery was the preferred second arterial conduit rather than a second internal thoracic artery in Ontario.
Another important observation was the difference in off-pump cases between MAG and SAG in the unadjusted cohorts (38.6% versus 7.8%, respectively). Although the rate of off-pump cases post PSM was balanced, the pre-PSM data suggest that MAG cases are frequently performed off-pump, and as a consequence, MAG might be a surrogate for off-pump surgeon, in Ontario. The sensitivity analysis that controlled for institution should also mitigate this possible effect to some degree.
Some authors recommend that saphenous veins should be avoided entirely in CABG surgery (total arterial revascularization). 30 The objective of this study was the assessment of incremental arterial revascularization, specifically the use of 3 versus 2 arterial grafts rather than the assessment of total arterial revascularization. Based on the average numbers of grafts in the 3Art and 2Art groups, we estimate that there was a mean of 0.8 and 1.7 saphenous vein grafts per patient in the 2 cohorts respectively.
Strengths and Limitations
This is the largest multi-center analysis of the outcomes of CABG with 3 versus 2 arterial grafts, reporting all relevant adverse events for this population. Both CorHealth's database and long-term follow-up codes utilized have been previously validated, demonstrating the accuracy of the data analyzed. To account for imbalances, PSM with an extensive number of baseline covariates was performed, including factors not frequently adjusted, such as income quintile and distance to health care provider, which might affect the health status of an individual. We chose to match for the extent of coronary disease and not the number of grafts. The number of grafts was slightly higher in the 3Art versus 2Art cohort (mean difference 0.07 grafts/patient); the difference was greater comparing MAG versus SAG (mean difference 0.24 grafts/patient). This could bias the results slightly in favor of the 3Art versus the 2Art group, and in favor of the MAG versus the SAG group. Nevertheless, a sensitivity analysis adjusting for total number of bypasses did not show any difference in the outcomes between the 3Art and 2 Art groups. Additional study limitations from our study are the lack of information regarding use of sequential grafts, target vessel bypassed, vessel size, or completeness of revascularization.
Any matching procedure cannot adjust for unmeasured confounders, including the surgeon's subjective decision toward a particular grafting strategy. 31 Further limitations of the study include its retrospective nature and the use of administrative databases, which despite the high sensitivity and predictive value of the codes used, 17 its accuracy will never reach the level of a well-designed randomized controlled trial, with diligent follow-up.
32
Conclusion
CABG with 3 arterial grafts was not associated with higher intraoperative risk nor with better clinical outcomes at 8-year follow-up, compared with CABG with 2 arterial grafts. CABG with >1 arterial graft is more popular in the contemporary era and is associated with better short-and long-term outcomes, compared with single arterial CABG.
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